Osteoporosis: nonclinical evaluation of drugs intended for treatment
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Guidance for industry
- Contributor(s):
- United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Drug Evaluation and Research (U.S.), issuing body.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, August 2019
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Bone Density Conservation Agents -- therapeutic use Drug Evaluation, Preclinical -- standards Osteoporosis -- drug therapy Anabolic Agents Biological Products Bone Density Research Design Toxicity Tests -- standards Animals Humans United States United States. Department of Health and Human Services. United States. Food and Drug Administration.
- Genre(s):
- Technical Report
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (8 pages)).
- NLM Unique ID:
- 101760325 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101760325